What is the market doing?
What the tape says about COGT
Cogent Biosciences, Inc. is +238% over the past year while the S&P 500 is +23%: 215 points ahead of the market.
+238%
1-year return · S&P 500 +23%
- vs 200-day average
- +3.8%
vs 200-day average · close to trend
- RSI (14)
- 29
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- −14%
Below its 52-week high
Details›
- Last close2026-08-26
- $36.71
- 1 monthS&P 500 +3.7%
- −8.8%
- 1 yearS&P 500 +23%
- +238%
- 5 yearsS&P 500 +87%
- +513%
- vs 50-day average$36.95
- −0.64%
- 52-week high
- $42.84
- 52-week low
- $10.93
- Annualised volatility
- 104%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$370M
| Year | Return |
|---|---|
| 2026 (year to date) | +3.4% |
| 2025 | +355% |
| 2024 | +33% |
| 2023 | −49% |
| 2022 | +35% |
| 2021 | −24% |
| 2020 | +290% |
| 2019 | −84% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | −1.0% |
| Feb | 8 | 2 of 8 | −0.88% |
| Mar | 8 | 3 of 8 | −5.1% |
| Apr | 9 | 2 of 9 | −6.4% |
| May | 9 | 5 of 9 | +4.5% |
| Jun | 9 | 6 of 9 | +13% |
| Jul | 9 | 7 of 9 | +62% |
| Aug | 9 | 5 of 9 | +10% |
| Sep | 8 | 3 of 8 | −11% |
| Oct | 8 | 4 of 8 | −1.1% |
| Nov | 8 | 1 of 8 | +4.6% |
| Dec | 8 | 2 of 8 | −9.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.